Clinical features and immunohistochemical changes of pituitary apoplexy

Journal of Clinical Neuroscience

Volumn 16, Issue 1, 2009, Pages 64-68

  Mou, Chengzhi ^a   Han, Tao ^b   Zhao, Hao ^b   Wang, Shaoguang ^c   Qu, Yuanming ^a  

^a SHANDONG UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c Department of Neurosurgery   (China)

Author keywords

Immunohistochemistry; Pituitary adenoma; Pituitary apoplexy

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BROMOCRIPTINE; CORTICOTROPIN; CYCLINE; GELATINASE B; GROWTH HORMONE; LIOTHYRONINE; PROLACTIN; SECURIN; THYROTROPIN; THYROXINE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EYE MOVEMENT DISORDER; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; HEADACHE; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERTHERMIA; HYPOPHYSIS ADENOMA; HYPOPHYSIS APOPLEXY; HYPOPHYSIS FUNCTION; IMMUNOHISTOCHEMISTRY; INJURY; MAJOR CLINICAL STUDY; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TUMOR VOLUME; UPPER RESPIRATORY TRACT INFECTION; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; VOMITING;

ADENOMA; ADULT; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH HORMONE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PITUITARY APOPLEXY; PITUITARY NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 56949096890     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2008.02.012     Document Type: Article

References (27)

1. Semple P.L., Webb M.K., de Villiers J.C., et al. Pituitary apoplexy. Neurosurgery 56 (2005) 65-72
2. Wakai S., Fukushina T., Teremoto A., et al. Pituitary apoplexy: Its incidence and clinical significance. J Neurosurg 33 (1981) 561-568
3. Elsasser Imboden P.N., De Tribolet N., Lobrinus A., et al. Apoplexy in pituitary macroadenoma: eight patients presenting in 12 months. Medicine 84 (2005) 188-196
4. Biousse V., and Makki A. Pituitary apoplexy. Rev Neurol 161 (2005) 587-589
5. Bhattacharrya A., Tymms D.J., and Naqvi N. Asymptomatic pituitary apoplexy after aortocoronary bypass surgery. Int J Clin Pract 53 (1999) 394-395
6. Sha C., Gao P., Yang Y., et al. Diagnosis and treatment of subclinical pituitary apoplexy: report of 21 cases. Zhonghua Wai Ke Za Zhi 40 (2002) 755-757
7. Zhang X., Horwitz G A., Heaney A.P., et al. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. Clin Endocrinol Metab 84 (1999) 761-767
8. Heaney A P., Fernando M., and Melmed S. Functional role of estrogen in pituitary tumor pathogenesis. J Clin Invest 109 (2002) 277-283
9. Yokoyama S., Hirano H., Moroki K., et al. Are nonfunctioning pituitary adenomas extending into the cavernous sinus aggressive and/or invasive?. Neurosurgery 49 (2001) 857-863
10. Liu W., Kunishio K., Matsumoto Y., et al. Matrix metalloproteinase-2 expression correlates with cavernous sinus invasion in pituitary adenomas. J Clin Neurosci 12 (2005) 791-794
11. Naganuma H., Satoh E., and Nukui H. Technical considerations of transsphenoidal removal of fibrous pituitary adenomas and evaluation of collagen content and subtype in the adenomas. Neurol Med Chir 42 (2002) 202-212
12. Sáez C., Japón M.A., Ramos-Morales F., et al. hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene 18 (1999) 5473-5476
13. Fraioli B., Esposito V., Palma L., et al. Hemorrhagic pituitary adenomas: clinicopathological features and surgical treatment. Neurosurgery 27 (1990) 741-748
14. Riedl M., Clodi M., Kotzmann H., et al. Apoplexy of a pituitary macroadenoma with reversible third, fourth and sixth cranial nerve palsies following administration of hypothalamic releasing hormones: MR features. Eur J Radiol 36 (2000) 1-4
15. Carral San Laureano F., Gavilan Villarejo I., Olveira Fuster G., et al. Pituitary apoplexy: retrospective study of 9 patients with hypophyseal adenoma. Ann Med Interna 18 (2001) 582-586
16. Deb S. Clinical significance of pituitary apoplexy. J Indian Med Assoc 96 (1998) 302-303
17. Lubina A., Olchovsky D., Berezin M., et al. Management of pituitary apoplexy: clinical experience with 40 patients. Acta Neurochir 147 (2005) 151-157
18. Randeva H.S., Schoebel J., Byrne J., et al. Classical pituitary apoplexy: clinical features, management and outcome. Clin Endocrinol 51 (1999) 181-188
19. Arita K., Kurisu K., Tominaga A., et al. Thickening of sphenoid sinus mucosa during the acute stage of pituitary apoplexy. J Neurosurg 95 (2001) 897-901
20. Becker G., Kocher M., Kortmann R.D., et al. Radiation therapy in the multimodal treatment approach of pituitary adenoma. Strahlenther Onkol 178 (2002) 173-186
21. Matsuura I., Saeki N., Kubota M., et al. Infarction followed by hemorrhage in pituitary adenoma due to endocrine stimulation test. Endocr J 48 (2001) 493-498
22. Chen Z., Murray A.W., and Quinlan J.J. Pituitary apoplexy presenting as unilateral third cranial nerve palsy after coronary artery bypass surgery. Anesth Analg 98 (2004) 46-48
23. Ishikawa H., Heaney A.P., Yu R., et al. Human pituitary tumor transforming gene induces angiogenesis. J Clin Endocrinol Metab 86 (2001) 867-874
24. Shekhar M.P., Werdell J., Santner S.J., et al. Breast stroma plays a dominant regulatory role in breast epithelial growth and differentiation: implications for tumor development and progression. Cancer Res 61 (2001) 1320-1326
25. Kim I., Kim H.G., Moon S.O., et al. Angiopotietin-1 induces endothelial cell sprouting through the activation of focal adhesion kinase and plasm in secretion. Circ Res 86 (2000) 952-959
26. Curran S., and Murray G.I. Matrix metalloprotei.nases in tumor invasion and metastasis. J Pathol 189 (1999) 300-308
27. Bolton W.E., Mikulkawk, Healy C.G., et al. Expression of proliferation associated antigen in the cell cycle of synchronized mammalian cells. Cytometry 13 (1992) 117-126